Prelude Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-59,592
| Closed | -$1.98M | – | 1550 |
|
|
2022
Q4 | $1.98M | Sell |
59,592
-16,436
| -22% | -$546K | 0.1% | 201 |
|
|
2022
Q3 | $2.4M | Buy |
+76,028
| New | +$2.4M | 0.09% | 185 |
|
|
2020
Q4 | – | Sell |
-318
| Closed | -$5K | – | 1748 |
|
|
2020
Q3 | $5K | Buy |
318
+200
| +169% | +$3.15K | ﹤0.01% | 1187 |
|
|
2020
Q2 | $3K | Sell |
118
-2,106
| -95% | -$53.5K | ﹤0.01% | 1220 |
|
|
2020
Q1 | $19K | Buy |
2,224
+2,201
| +9,570% | +$18.8K | ﹤0.01% | 666 |
|
|
2019
Q4 | $0 | Buy |
+23
| New | – | ﹤0.01% | 1868 |
|
|
2019
Q3 | – | Sell |
-11,187
| Closed | -$133K | – | 1717 |
|
|
2019
Q2 | $133K | Buy |
+11,187
| New | +$133K | 0.01% | 561 |
|
|
2019
Q1 | – | Sell |
-752
| Closed | -$13K | – | 1863 |
|
|
2018
Q4 | $13K | Sell |
752
-510
| -40% | -$8.82K | ﹤0.01% | 990 |
|
|
2018
Q3 | $19K | Buy |
1,262
+45
| +4% | +$677 | ﹤0.01% | 975 |
|
|
2018
Q2 | $19K | Sell |
1,217
-5,211
| -81% | -$81.4K | ﹤0.01% | 1092 |
|
|
2018
Q1 | $91K | Buy |
6,428
+3,536
| +122% | +$50.1K | 0.01% | 794 |
|
|
2017
Q4 | $40K | Sell |
2,892
-8,308
| -74% | -$115K | ﹤0.01% | 876 |
|
|
2017
Q3 | $160K | Buy |
11,200
+1,400
| +14% | +$20K | 0.01% | 652 |
|
|
2017
Q2 | $154K | Sell |
9,800
-15,692
| -62% | -$247K | 0.01% | 591 |
|
|
2017
Q1 | $352K | Buy |
+25,492
| New | +$352K | 0.03% | 351 |
|
|
2015
Q4 | – | Sell |
-1,800
| Closed | -$31K | – | 1669 |
|
|
2015
Q3 | $31K | Buy |
+1,800
| New | +$31K | ﹤0.01% | 1084 |
|
|
2015
Q2 | – | Sell |
-1,900
| Closed | -$36K | – | 2035 |
|
|
2015
Q1 | $36K | Sell |
1,900
-200
| -10% | -$3.79K | 0.01% | 1507 |
|
|
2014
Q4 | $35K | Buy |
+2,100
| New | +$35K | 0.01% | 1454 |
|
|
2013
Q4 | – | Sell |
-390
| Closed | -$9K | – | 1855 |
|
|
2013
Q3 | $9K | Buy |
+390
| New | +$9K | ﹤0.01% | 1194 |
|